Company Overview
- Headquarters
- Three Bala Plaza East Suite 506, Bala Cynwyd PA
- Website
- larimartx.com
- Phone
- (844) 511-****
- Employees
- 40
- Founded in
- 2016
- Industry
- BioTech/Drugs
- NAICS Code
- 54, 541, 5417
- SIC Code
- 28, 283
Financials & Stats
Revenue
$1B
Total Funding Amount
$23M
Who is Larimar Therapeutics Inc
Larimar Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Bala Cynwyd, Pennsylvania. The company employs 40 people and generates approximately $1 million in annual revenue. Larimar Therapeutics focuses on developing treatments for complex rare diseases. Their primary compound, CTI-1601, is undergoing clinical trials as a potential treatment for Friedreich's ataxia, a genetic disease. Additionally, Larimar aims to utilize its intracellular delivery platform to design further fusion proteins targeting rare diseases involving deficiencies in intracellular bioactive compounds. Larimar's unique intracellular delivery platform distinguishes the company by enabling targeted therapies for specific genetic disorders. This platform allows them to design therapies aimed at delivering crucial compounds directly within cells, addressing the underlying causes of rare diseases. For further inquiries, visit Larimar Therapeutics' website at larimartx.com.
Company Leadership
Larimar Therapeutics Inc Tech Stack
Companies Similar to Larimar Therapeutics Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Larimar Therapeutics Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 1M | 11 | 2007 | ||
| 1M | 4 | |||
| 1M | 4 | Washington, WA | 1994 | |
| 1M | 32 | New York, NY | 1983 | |
| 1M | 3 |